Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -16.43% is 62% above its 5-year average of -43.46%, around the middle of its 5-year range (-81.28%–68.81%).
As of the fiscal period ended Tuesday, June 30, 2026. 57.13% above its 12-month average of -38.33%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -16.43%.
RETURN ON EQUITY (ROE)
-16.43%
RETURN ON EQUITY (ROE) AVG TTM
-38.33%
RETURN ON EQUITY (ROE) AVG 3Y
-43.49%
RETURN ON EQUITY (ROE) AVG 5Y
-43.46%
RETURN ON EQUITY (ROE) AVG 10Y
-63.65%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+57.13%
CURRENT VS 3Y AVG
+62.21%
CURRENT VS 5Y AVG
+62.18%
CURRENT VS 10Y AVG
+74.18%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+60.88%
vs the sector median at left
Ovid Therapeutics Inc.
Market Cap
$446.87M
Return on Equity (ROE)
-16.43%
TTM Avg
-38.33%
3Y Avg
-43.49%
5Y Avg
-43.46%
Market Cap
$447.43M
Return on Equity (ROE)
-52.56%
TTM Avg
-31.09%
3Y Avg
-101.75%
5Y Avg
-86.54%
Market Cap
$441.33M
Return on Equity (ROE)
-97.92%
TTM Avg
-59.21%
3Y Avg
-49.84%
5Y Avg
-46.25%
Market Cap
$439.25M
Return on Equity (ROE)
-0.01%
TTM Avg
-61.70%
3Y Avg
-96.25%
5Y Avg
-81.28%
Market Cap
$454.45M
Return on Equity (ROE)
89.43%
TTM Avg
81.07%
3Y Avg
67.39%
5Y Avg
61.90%
Market Cap
$436.34M
Return on Equity (ROE)
-160.85%
TTM Avg
-225.75%
3Y Avg
-186.61%
5Y Avg
-129.85%
Market Cap
$464.77M
Return on Equity (ROE)
-56.26%
TTM Avg
-59.48%
3Y Avg
-54.76%
5Y Avg
-34.52%
Market Cap
$429.18M
Return on Equity (ROE)
-6.60%
TTM Avg
-10.82%
3Y Avg
-11.36%
5Y Avg
-7.59%
Market Cap
$428.33M
Return on Equity (ROE)
-38.32%
TTM Avg
-35.34%
3Y Avg
12.60%
5Y Avg
10.50%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | $446.87M | -16.43% | -38.33% | -43.49% | -43.46% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $447.43M | -52.56% | -31.09% | -101.75% | -86.54% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $441.33M | -97.92% | -59.21% | -49.84% | -46.25% |
| Assembly Biosciences, Inc. (ASMB)vs › | $439.25M | -0.01% | -61.70% | -96.25% | -81.28% |
| NRC Health (NRC)vs › | $454.45M | 89.43% | 81.07% | 67.39% | 61.90% |
| NeuroPace, Inc. (NPCE)vs › | $436.34M | -160.85% | -225.75% | -186.61% | -129.85% |
| Sight Sciences, Inc. (SGHT)vs › | $464.77M | -56.26% | -59.48% | -54.76% | -34.52% |
| NeoGenomics, Inc. (NEO)vs › | $429.18M | -6.60% | -10.82% | -11.36% | -7.59% |
| Tectonic Therapeutic, Inc. (TECX)vs › | $428.33M | -38.32% | -35.34% | 12.60% | 10.50% |
| Cerus Corporation (CERS)vs › | $468.55M | -9.69% | -30.79% | -49.02% | -53.00% |
ROE
-16.4%
ROA
-14.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -16.43% |
| 2026-03-31 | -12.19% |
| 2025-12-31 | -13.33% |
| 2025-09-30 | -81.28% |
| 2025-06-30 | -68.43% |
| 2025-03-31 | -42.13% |
| 2024-12-31 | -38.74% |
| 2024-09-30 | -42.60% |
| 2024-06-30 | -33.46% |
| 2024-03-31 | -64.74% |
| 2023-12-31 | -59.61% |
| 2023-09-30 | -47.90% |
| 2023-06-30 | -44.48% |
| 2023-03-31 | -42.51% |
| 2022-12-31 | -40.95% |
| 2022-09-30 | -47.74% |
| 2022-06-30 | -44.19% |
| 2022-03-31 | -41.47% |
| 2021-12-31 | 68.81% |
| 2021-09-30 | 64.36% |
| 2021-06-30 | 58.91% |
| 2021-03-31 | 52.01% |
| 2020-12-31 | -185.73% |
| 2020-09-30 | -119.38% |
| 2020-06-30 | -249.93% |
| 2020-03-31 | -129.64% |
| 2019-12-31 | -86.34% |
| 2019-09-30 | -187.68% |
| 2019-06-30 | -116.02% |
| 2019-03-31 | -91.88% |
| 2018-12-31 | -133.95% |
| 2018-09-30 | -100.14% |
| 2018-06-30 | -75.98% |
| 2018-03-31 | -60.69% |
| 2017-12-31 | -77.67% |
| 2017-09-30 | -66.06% |
| 2017-06-30 | -57.29% |
| 2017-03-31 | -125.12% |
| 2016-12-31 | -45.47% |
| 2016-09-30 | -32.52% |
